clodronic acid has been researched along with Bowel Diseases, Inflammatory in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (75.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Feng, Y; Fox, JG; Ge, Z; McCabe, A; Mobley, M; Muthupalani, S; Rickman, B; Van Rooijen, N | 1 |
Chiba, T; Honjo, T; Ikuta, K; Kawanami, C; Matsuura, M; Nakase, H; Okazaki, K; Tabata, Y; Tamaki, H; Watanabe, N | 1 |
Chiba, T; Nakase, H; Okazaki, K; Tabata, Y | 1 |
Abitbol, V; Allez, M; Bouhnik, Y; Briot, K; Charachon, A; Chaussade, S; Coffin, B; Lamarque, D; Roux, C; Roy, C; Seksik, P | 1 |
1 review(s) available for clodronic acid and Bowel Diseases, Inflammatory
Article | Year |
---|---|
Biodegradable microspheres targeting mucosal immune-regulating cells: new approach for treatment of inflammatory bowel disease.
Topics: Absorbable Implants; Analgesics, Non-Narcotic; Animals; Anti-Inflammatory Agents; Clodronic Acid; Dexamethasone; Disease Models, Animal; Drug Delivery Systems; Humans; Inflammatory Bowel Diseases; Interleukin-10; Intestinal Mucosa; Mice; Microspheres; Monocytes | 2003 |
1 trial(s) available for clodronic acid and Bowel Diseases, Inflammatory
Article | Year |
---|---|
A double-blind placebo-controlled study of intravenous clodronate for prevention of steroid-induced bone loss in inflammatory bowel disease.
Topics: Absorptiometry, Photon; Adult; Bone Density; Bone Density Conservation Agents; Clodronic Acid; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Femur Neck; Follow-Up Studies; Glucocorticoids; Humans; Inflammatory Bowel Diseases; Injections, Intravenous; Lumbar Vertebrae; Male; Middle Aged; Osteoporosis; Retrospective Studies; Thoracic Vertebrae; Treatment Outcome | 2007 |
2 other study(ies) available for clodronic acid and Bowel Diseases, Inflammatory
Article | Year |
---|---|
Systemic macrophage depletion inhibits Helicobacter bilis-induced proinflammatory cytokine-mediated typhlocolitis and impairs bacterial colonization dynamics in a BALB/c Rag2-/- mouse model of inflammatory bowel disease.
Topics: Animals; Cecum; Clodronic Acid; Colitis; Cytokines; Disease Models, Animal; DNA-Binding Proteins; Helicobacter; Helicobacter Infections; Humans; Inflammation Mediators; Inflammatory Bowel Diseases; Interleukin-10; Macrophages; Mice; Mice, Inbred BALB C | 2012 |
Elimination of local macrophages in intestine prevents chronic colitis in interleukin-10-deficient mice.
Topics: Animals; Biopsy, Needle; Chronic Disease; Clodronic Acid; Colitis; Disease Models, Animal; Female; Flow Cytometry; Immunohistochemistry; Inflammatory Bowel Diseases; Interleukin-10; Macrophages; Mice; Mice, Inbred C57BL; Microscopy, Fluorescence; Microspheres; Reference Values; Sensitivity and Specificity | 2003 |